This trial will test how well the FDG-PET scan and blood tests for HPV can detect leftover cervical cancer cells after treatment.
1 Primary · 1 Secondary · Reporting Duration: up to 5 years
Experimental Treatment
64 Total Participants · 1 Treatment Group
Primary Treatment: [18-F]- FDG - PET · No Placebo Group · N/A
Age 18+ · Female Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: